Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Homologies between Bauhinia forficata Link subsp. pruinosa and pancreatic beta-cell specific transcriptional activator: a starting point for drug design new in diabetes?

Authors: Luis Jesuino de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Paulo Roberto Santana de Melo, Hudson Sá Sodré, Carlos Alberto Menezes, Alcina Maria Vinhaes Bittencourt

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Diabetes mellitus (DM) is a chronic disease with an ever-increasing incidence in world and has become the object of scientific research into the search for novel therapeutic alternatives. Bauhinia forficata Link, known locally as cow foot, has been traditionally used as tea in folk medicine of Brazil for treatment of DM. …
Metadata
Title
Homologies between Bauhinia forficata Link subsp. pruinosa and pancreatic beta-cell specific transcriptional activator: a starting point for drug design new in diabetes?
Authors
Luis Jesuino de Oliveira Andrade
Gabriela Correia Matos de Oliveira
Paulo Roberto Santana de Melo
Hudson Sá Sodré
Carlos Alberto Menezes
Alcina Maria Vinhaes Bittencourt
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A245

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue

Meeting abstract

Increased oxidative stress according to number of risk factors in metabolic syndrome patients

Meeting abstract

Effects of long-term reducing gastroplasty roux-y on body weight and clinical metabolic comorbidities in a bariatric surgery service of a university hospital

Meeting abstract

Chronicity, self care, social and family support: how the patient has?

Meeting abstract

Frequency of metabolic syndrome in obesity: a comparison of current criteria of IDF and NCEP-ATPIII

Meeting abstract

New onset diabetes mellitus after kidney transplant: prevalence and risk factors

Meeting abstract

Relationship between insulin administration and substrates oxidation during continuous aerobic exercise in adolescents with type 1 diabetes mellitus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits